These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Nedelsky NB; Pennuto M; Smith RB; Palazzolo I; Moore J; Nie Z; Neale G; Taylor JP Neuron; 2010 Sep; 67(6):936-52. PubMed ID: 20869592 [TBL] [Abstract][Full Text] [Related]
5. Cell biological approaches to investigate polyglutamine-expanded AR metabolism. Cooper LJ; Merry DE Methods Mol Biol; 2013; 1017():241-53. PubMed ID: 23719921 [TBL] [Abstract][Full Text] [Related]
6. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Polanco MJ; Parodi S; Piol D; Stack C; Chivet M; Contestabile A; Miranda HC; Lievens PM; Espinoza S; Jochum T; Rocchi A; Grunseich C; Gainetdinov RR; Cato AC; Lieberman AP; La Spada AR; Sambataro F; Fischbeck KH; Gozes I; Pennuto M Sci Transl Med; 2016 Dec; 8(370):370ra181. PubMed ID: 28003546 [TBL] [Abstract][Full Text] [Related]
7. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Palazzolo I; Burnett BG; Young JE; Brenne PL; La Spada AR; Fischbeck KH; Howell BW; Pennuto M Hum Mol Genet; 2007 Jul; 16(13):1593-603. PubMed ID: 17470458 [TBL] [Abstract][Full Text] [Related]
8. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy. Nihei Y; Ito D; Okada Y; Akamatsu W; Yagi T; Yoshizaki T; Okano H; Suzuki N J Biol Chem; 2013 Mar; 288(12):8043-8052. PubMed ID: 23364790 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045 [TBL] [Abstract][Full Text] [Related]
10. Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. Furutani T; Takeyama K; Tanabe M; Koutoku H; Ito S; Taniguchi N; Suzuki E; Kudoh M; Shibasaki M; Shikama H; Kato S J Pharmacol Exp Ther; 2005 Nov; 315(2):545-52. PubMed ID: 16079302 [TBL] [Abstract][Full Text] [Related]
12. Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA. Karliner J; Liu Y; Merry DE Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2321408121. PubMed ID: 38976730 [TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model. Doi H; Adachi H; Katsuno M; Minamiyama M; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Qiang Q; Tanaka F; Yanagawa T; Warabi E; Ishii T; Sobue G J Neurosci; 2013 May; 33(18):7710-27. PubMed ID: 23637164 [TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Beauchemin AM; Gottlieb B; Beitel LK; Elhaji YA; Pinsky L; Trifiro MA Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):285-97. PubMed ID: 11719263 [TBL] [Abstract][Full Text] [Related]
16. B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy. Palazzolo I; Nedelsky NB; Askew CE; Harmison GG; Kasantsev AG; Taylor JP; Fischbeck KH; Pennuto M J Neurosci Res; 2010 Aug; 88(10):2207-16. PubMed ID: 20336775 [TBL] [Abstract][Full Text] [Related]
17. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791 [TBL] [Abstract][Full Text] [Related]
18. Impaired Nuclear Export of Polyglutamine-Expanded Androgen Receptor in Spinal and Bulbar Muscular Atrophy. Arnold FJ; Pluciennik A; Merry DE Sci Rep; 2019 Jan; 9(1):119. PubMed ID: 30644418 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel polyglutamine-expanded aggregation species in spinal and bulbar muscular atrophy. Berger TR; Montie HL; Jain P; Legleiter J; Merry DE Brain Res; 2015 Dec; 1628(Pt B):254-264. PubMed ID: 26453288 [TBL] [Abstract][Full Text] [Related]
20. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Bott LC; Badders NM; Chen KL; Harmison GG; Bautista E; Shih CC; Katsuno M; Sobue G; Taylor JP; Dantuma NP; Fischbeck KH; Rinaldi C Hum Mol Genet; 2016 May; 25(10):1979-1989. PubMed ID: 26962150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]